Cell and gene therapies (CGTs) have transformed what is possible for patients – but they bring a new level of complexity and demand new approaches in manufacturing, quality, and control strategies. This panel will explore some of the industry’s challenges and risks, and discuss approaches to reliably deliver CGTs to patients.

Our panelists will cover topics including Quality by Design, contamination control, and manufacturing network strategies to drive success. Join us for an engaging evening, learn from the expertise of the panelists, and gain tools to get ahead in an evolving industry. This event is hosted by ISPE Women in Pharma and the ATMP Community of Practice. Networking to follow the panel.